Everyday HealthFDA Approves Mounjaro, a Novel Once-a-Week Medication to Treat Type 2 DiabetesMay 16, 2022Becky UphamBy Becky Uphammore_vert
MedCity NewsEli Lilly’s diabetes portfolio grows with FDA nod for projected blockbuster drugMay 15, 2022Frank VinluanBy Frank Vinluanmore_vert
PR NewswireFDA approves Lilly's Mounjaro™ (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the ...May 13, 2022more_vert
FiercePharmaMounjaro diabetes drug by Lilly wins FDA blessingMay 13, 2022Kevin DunleavyBy Kevin Dunleavymore_vert